| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | President &CEO
3 companies
Higgins John L serves as a Director at OABI and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 9 buys and 48 sells. Those positions are worth an estimated $33.3M at current prices.
Historically, Higgins John L's trades have earned a middling insider score of 66/100 across 18 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +8.8%.
The biggest single holding is LGND (~$27.7M) as Director. The recent filings there lean toward selling, a net 341,329 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | OABI Omniab, Inc. | Director | Buy | 77,261 | $1.39 | $107,706.87 | +2.7% | +19.6% | - | |
| May 12, 2025 | OABI Omniab, Inc. | Director | Buy | 65,000 | $1.44 | $93,600.00 | +2.3% | +37.1% | - | |
| Mar 21, 2025 | OABI Omniab, Inc. | Director | Buy | 4,000 | $2.28 | $9,120.00 | +0.1% | -37.2% | -30.8% | |
| Mar 20, 2025 | OABI Omniab, Inc. | Director | Buy | 125,750 | $2.35 | $295,512.50 | +4.8% | -27.3% | -22.9% | |
| May 14, 2024 | TECH Bio-Techne Corp | Director | Sale+OE | 4,000 | $83.84 | $335,377.20 | -9.9% | -14.7% | -43.1% | |
| May 23, 2023 | OABI Omniab, Inc. | Director | Sale+OE | 9,000 | $4.05 | $36,450.00 | -0.4% | +34.6% | +2.1% | |
| May 19, 2023 | OABI Omniab, Inc. | Director | Sale+OE | 1,000 | $4.05 | $4,050.00 | - | +51.6% | +15.3% | |
| May 18, 2023 | OABI Omniab, Inc. | Director | Sale+OE | 50,000 | $3.89 | $194,500.00 | -2.0% | +51.3% | +13.5% | |
| Dec 16, 2022 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 10,000 | $61.87 | $618,657.00 | -2.3% | +17.7% | +7.5% | |
| Nov 17, 2022 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 10,000 | $78.32 | $783,173.00 | -2.3% | -6.9% | -26.2% |